-
News
ReelTime’s Discount Ad Brokers Generates Nearly $250,000 in Booked Revenue in January as Resort Media Bookings Begin to Return on Optimism of a Post Vaccine Travel Surge
[ad_1] Seattle, WA – (NewMediaWire) – February 11, 2021 – ReelTime VR/ReelTime Media (OTC:RLTR): ReelTime’s Discount Ad Brokers (DAB), a 15…
Read More » -
Viking Energy Announces Reverse Stock Split
[ad_1] Houston, TX – (NewMediaWire) – February 12, 2021 – Viking Energy Group,Inc.(OTCQB: VKIN) (“Viking” or the “Company”) today announced a reverse stock…
Read More » -
Light Media Revenues Surge 500%
[ad_1] Atlanta, GA – (NewMediaWire) – February 12, 2021 – Light Media (OTC MARKETS: LGMH), Global Media Specialist, announced today…
Read More » -
SmallCapsDaily: Lobe Sciences is a Major Opportunity In the Psychedelics Medicine Industry
[ad_1] New York, NY – (NewMediaWire) – February 12, 2021 – Lobe Sciences Ltd., (OTC Pink: GTSIF), a growth-oriented research,…
Read More » -
News
Calvin B. Taylor Bankshares, Inc. (OTCQX: TYCB), Parent Company of Calvin B. Taylor Bank, Today Announced that Its Board of Directors has Elected Hale Harrison as Chair of the Board of Directors of the Company and the Bank
[ad_1] Berlin, Maryland – (NewMediaWire) – February 12, 2021 – Calvin B. Taylor Bankshares, Inc. (the “Company”) (OTCQX: TYCB), parent…
Read More » -
Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market
[ad_1] Vancouver – (NewMediaWire) – February 12, 2021 – Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN)…
Read More » -
Tauriga Sciences Inc. to Commence Development of its 1st Full Spectrum CBD Infused Edibles Product Line
[ad_1] NEW YORK, NY – (NewMediaWire) – February 12, 2021 – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a…
Read More » -
Featured
Lobe Sciences: A Hidden Gem In The Psychedelics Research Space
As growth investors focused on the small caps domain, we are constantly on the lookout for sectors which are expected…
Read More » -
News
AngioSoma and its Subsidiary SomaCeuticals Announce Amended and Restated Execution of Global License for Multiple Sclerosis Patent
[ad_1] Houston, TX – (NewMediaWire) – February 11, 2021 – AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”), through its wholly-owned subsidiary,…
Read More »